{
  "id": "OPM-2025-0004-0601",
  "title": "Comment from Karin Cox",
  "category": "",
  "analysis": {
    "stance": "Against",
    "themes": [
      "Merit-based system concerns",
      "Due process/employee rights",
      "Politicization concerns",
      "Scientific integrity"
    ],
    "key_quote": "To proceed otherwise would risk a reduction in the quality of US research -- including biomedical research touching upon the diseases that concern many Americans, like Alzheimer's and cancer -- due to the appointment of individuals who are insufficiently qualified, and/or approach science as a means to advancing their political goals, as opposed an objective pursuit of evidence-based knowledge.",
    "rationale": "The comment expresses concern about the politicization of grantmaking and emphasizes the need for scientific expertise in the process, which aligns with opposition to the proposed rule. It highlights the risks to research quality and integrity, indicating a clear stance against the rule."
  },
  "occurrence_number": 0,
  "duplicate_of": ""
}